FAS and ovarian carcinoma: In 75 peritoneal and pleural effusions, Dong et al. [97] also observed that tumor cells expressing high levels of Fas conferred a poor response to chemotherapy, including platinum treatment, in ovarian cancer patients, but was not associated with disease-free progression survival or overall survival.